Skip to main content
. 2020 Mar 4;10(9):3994–4005. doi: 10.7150/thno.43227

Table 3.

Ex vivo tumor-to-background ratio per dose cohort.

Dose-cohort TBR
Visualization Spectroscopy
10mg 1.61 ± 0.93 2.86 ± 0.29
25mg 2.02 ± 0.55 1.99 ± 1.62
50mg 1.81 ± 0.32 1.48 ± 0.52
15mg* 3.06 ± 0.43 2.50 ± 0.19
25mg* 3.10 ± 2.53 2.81 ± 1.27

Median tumor-to-background ratios shown both for fluorescence visualization using a closed-field imaging device and quantification of intrinsic fluorescence values using MDSFR/SFF spectroscopy.